scRNA-seq revealed R3HDM4’s predominant expression in cancer cell clusters, especially cycling/metastatic subsets, with low expression in immune/stromal cells; unlike bulk RNA-seq averaging signals, scRNA-seq pinpointed its cancer cell-specific pro-tumor effects and indirect TME influence. The gene discussed is R3HDM4; the disease is neoplasm.